Nillama, Mary Jewel .
HRN: 23-51-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2023
CEFUROXIME 500MG (TAB)
08/08/2023
08/14/2023
ORAL
500
BID
MSAF
Waiting Final Action
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes